openPR Logo
Press release

Key Drivers for “Migraine with Brainstem Aura Market" to Ensure Healthy Growth with Leading Players like Allergen Plc, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, AstraZeneca, Eisai Co., Ltd.

01-29-2019 08:35 AM CET | Health & Medicine

Press release from: Market Research Future

Key Drivers for “Migraine with Brainstem Aura Market"

Market Research Future has declared the expansion of the "Worldwide Migraine with Brainstem Aura Market Research Report which gives Market Size, Shares and Forecasts till 2023.

Migraine with Brainstem Aura Market -Highlights

A migraine with brainstem aura (MBA) is a rare form of migraine characterized by headaches that start in the lower part of the brain. The main symptoms of this migraine include double vision, dizziness, and lack of coordination among others.

A migraine with brainstem aura (MBA) is also known as basilar migraines or basilar artery migraine. The headache pain of this type of migraine generally starts on one side of the head and then gradually spreads to the other side.

The exact cause of this is unknown, but it is considered to be caused due to blood vessel constriction.

GET EXCLUSIVE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/6413

MBA can be caused in men and women of all ages. However, according to the Genetic and Rare Disease Information Center, this type of migraine is most common in adolescent women.

Currently, there is the absence of a permeant cure for this condition, but certain abortive and preventive medications are available.

The growing prevalence of migraine and raising awareness about rare types of migraines in developed economies are major drivers for the market growth.

According to the data by the Migraine Trust, 2017, it is estimated that about 2% of the world’s population suffers from a chronic migraine. Moreover, the rising need for better treatment approaches, increasing investment of biotechnology and pharmaceutical industries in research & development (R&D) are expected to boost the growth of the market.

On the other hand, side effects associated with basilar migraine treatment drugs may hamper the growth of the market during the forecast period.

Migraine with Brainstem Aura Market -Key Players

Allergen Plc
Merck & Co., Inc.
Pfizer, Inc.
GlaxoSmithKline Plc
Abbott Laboratories
AstraZeneca `
Eisai Co., Ltd.
Endo International Plc
Impax Laboratories
Eli Lily and Company
Johnson & Johnson

Migraine with Brainstem Aura Market -Segmentation

The global migraine with brainstem aura market has been segmented into diagnosis, treatment, distribution channel, and end user.

The market, by diagnosis, has been segmented into magnetic resonance imaging (MRI), computerized tomography (CT), and others.

Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/migraine-brainstem-aura-market-6405

The market, on the basis of treatment, has been segmented into abortive medication and preventive medication. The abortive medication segment has been segmented into non-steroidal anti-inflammatory drugs (NSAIDs), anti-nausea medications, ergotamine, and others.

The preventive medication segment has been further segmented into botox injections, antidepressants, and others.

On the basis of the distribution channel, the market has been segmented into retail pharmacies, hospital pharmacies, and others. The market, by end-user, has been segmented into hospital & clinics, diagnostic centers, and others.

Migraine with Brainstem Aura Market -Regional Analysis

Geographically, the Americas is expected to dominate the global migraine with brainstem aura market owing to the presence of a well-developed healthcare sector, rising prevalence of migraine, and growing expenditure for the healthcare sector.

Europe is expected to hold the second largest position in the global migraine with brainstem aura owing to the availability of funds for research and rising prevalence of migraine.

Asia-Pacific is expected to be the fastest growing market owing to the continuous developing economies and increasing regional expansion by major market players in the region.

Furthermore, the Middle East and Africa is expected to hold the least market share in the global migraine with brainstem aura market.

Some Points from Table of Content

Report Prologue
Introduction
2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

Research Methodology
3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

TOC Continued….!

GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/6413

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Drivers for “Migraine with Brainstem Aura Market" to Ensure Healthy Growth with Leading Players like Allergen Plc, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, AstraZeneca, Eisai Co., Ltd. here

News-ID: 1540760 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Migraine

Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share? The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size? The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market? The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes. Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market. The objectives outlined in the report are multifaceted and aimed at offering a comprehensive
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /